SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation

The p38 inhibitor SB202190 is a necessary component of the medium used for normal colorectal mucosa cultures. Sato et al. suggested that the primary activity of SB202190 may be EGFR signaling stabilization, causing an increased phosphorylation of Erk1-2 sustaining organoid proliferation. However, th...

Description complète

Détails bibliographiques

Auteurs principaux:	Delfina Costa, Roberta Venè, Simona Coco, Luca Longo, Francesca Tosetti, Stefano Scabini, Luca Mastracci, Federica Grillo, Alessandro Poggi, Roberto Benelli
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2023-02-01
Collection:	Cells
Sujets:	colorectal cancer organoid SB202190 BRAF Erk1-2
Accès en ligne:	https://www.mdpi.com/2073-4409/12/4/664
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!